A company, likely Amgen or Generate Biomedicines Inc, is leveraging the Chroma model for an AI platform, backed by co-development deals.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company, likely Amgen or Generate Biomedicines Inc, is leveraging the Chroma model for an AI platform, backed by co-development deals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Nvidia
American multinational technology company
Related events
- Jensen Huang is leading Nvidia through its AI buildout, while both Nvidia and Sherwin-Williams are currently under investment focus analysis.
- Jensen Huang is implementing a partnership strategy for Nvidia, with both companies benefiting from the current AI spending boom.
- Dell Technologies is utilizing Nvidia silicon to build AI factories, competing with Nvidia for enterprise AI infrastructure dollars.
- Nvidia is facing demands for testimony regarding the company's role in the ongoing US-China technology scrutiny.
- Goldman Sachs and BlackRock have signed MOUs regarding their participation in AI financing alongside Nvidia.